Isoprinosine's Immuno-Restorative Effect in Immunodepressed Patients with Uncomplicated Generalized Lymphadenopathy

This study focuses on immunodepressed patients, or individuals with a weakened immune system, who have uncomplicated generalized lymphadenopathy, a condition characterized by the enlargement of lymph nodes. The main goal is to investigate the effect of a drug called Isoprinosine in improving the immune response of these patients. The significance of this research lies in its potential to find a treatment that can restore the immune system's function in immunodepressed patients, thereby addressing an unmet need in their care. During this study, participants are randomly assigned to receive either Isoprinosine or a placebo, a substance that has no therapeutic effect, for a period of 28 days. The study continues to observe the participants for an additional 2 months after the treatment ends. The effect of Isoprinosine is measured by changes in certain immune system parameters, such as an increase in the activity of natural killer (NK) cells, total T-cells, and T-helper cells. These cells play crucial roles in defending the body against infections and diseases.